Literature DB >> 18053965

Effects of memantine on mitochondrial function.

Jenna McAllister1, Sangeeta Ghosh, Diana Berry, Melissa Park, Sina Sadeghi, Kai Xuan Wang, W Davis Parker, Russell H Swerdlow.   

Abstract

Because NMDA complex and mitochondrial function are related, we hypothesized memantine would influence mitochondrial function. We addressed this in vitro by studying the effects of chronic and acute memantine exposures on mitochondrial function. For acute exposure experiments, mitochondria were isolated from NT2 cells and assayed for electron transport chain (ETC) enzyme function and peroxide production in buffers containing up to 60uM memantine. For chronic exposure experiments, NT2 cells were maintained for at least two weeks in medium containing up to 60uM memantine, following which we assayed cells or their mitochondria for ETC enzyme activities, cytochrome oxidase protein levels, oxidative stress, calcium levels, and mitochondrial DNA levels. The ability of the NMDA receptor antagonist aminophosphonovaleric acid (APV) to modify memantine's mitochondrial effects was evaluated. Acute and chronic memantine similarly affected complex I (increased at high concentrations) and IV (decreased at high concentrations) V(max) activities. APV did not alter the effects of chronic memantine exposure on citrate synthase and complex IV. We detected a lower mitochondrial peroxide production rate with acute exposure, and an increased mitochondrial peroxide production rate with chronic exposure. Micromolar memantine concentrations affect mitochondria, some of these effects are directly mediated, and acute and chronic effects may differ.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18053965      PMCID: PMC2270256          DOI: 10.1016/j.bcp.2007.10.019

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  23 in total

Review 1.  Mitochondria and neuronal survival.

Authors:  D G Nicholls; S L Budd
Journal:  Physiol Rev       Date:  2000-01       Impact factor: 37.312

Review 2.  Mitochondria in Alzheimer's disease.

Authors:  Russell H Swerdlow; Stephen J Kish
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

Review 3.  Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species.

Authors:  Paul S Brookes; Anna-Liisa Levonen; Sruti Shiva; Paolo Sarti; Victor M Darley-Usmar
Journal:  Free Radic Biol Med       Date:  2002-09-15       Impact factor: 7.376

4.  Memantine in moderate-to-severe Alzheimer's disease.

Authors:  Barry Reisberg; Rachelle Doody; Albrecht Stöffler; Frederick Schmitt; Steven Ferris; Hans Jörg Möbius
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

5.  The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells.

Authors:  Sangeeta Ghosh; Nishant Patel; Douglas Rahn; Jenna McAllister; Sina Sadeghi; Geoffrey Horwitz; Diana Berry; Kai Xuan Wang; Russell H Swerdlow
Journal:  Mol Pharmacol       Date:  2007-03-26       Impact factor: 4.436

6.  Cytochrome oxidase deficiency in Alzheimer's disease.

Authors:  W D Parker; C M Filley; J K Parks
Journal:  Neurology       Date:  1990-08       Impact factor: 9.910

Review 7.  Calcium, ATP, and ROS: a mitochondrial love-hate triangle.

Authors:  Paul S Brookes; Yisang Yoon; James L Robotham; M W Anders; Shey-Shing Sheu
Journal:  Am J Physiol Cell Physiol       Date:  2004-10       Impact factor: 4.249

8.  Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging.

Authors:  Ana Navarro; Alberto Boveris
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-07-22       Impact factor: 3.619

9.  Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Authors:  Pierre N Tariot; Martin R Farlow; George T Grossberg; Stephen M Graham; Scott McDonald; Ivan Gergel
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

10.  Unique domain anchoring of Src to synaptic NMDA receptors via the mitochondrial protein NADH dehydrogenase subunit 2.

Authors:  Jeffrey R Gingrich; Kenneth A Pelkey; Sami R Fam; Yueqiao Huang; Ronald S Petralia; Robert J Wenthold; Michael W Salter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-06       Impact factor: 11.205

View more
  7 in total

1.  Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain.

Authors:  Gislaine Z Réus; Roberto B Stringari; Gislaine T Rezin; Daiane B Fraga; Juliana F Daufenbach; Giselli Scaini; Joana Benedet; Natália Rochi; Emílio L Streck; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2011-09-28       Impact factor: 3.575

Review 2.  Recent insights into the mode of action of memantine and ketamine.

Authors:  Jon W Johnson; Nathan G Glasgow; Nadezhda V Povysheva
Journal:  Curr Opin Pharmacol       Date:  2014-12-02       Impact factor: 5.547

3.  In Vitro Effects of Cognitives and Nootropics on Mitochondrial Respiration and Monoamine Oxidase Activity.

Authors:  Namrata Singh; Jana Hroudová; Zdeněk Fišar
Journal:  Mol Neurobiol       Date:  2016-09-23       Impact factor: 5.590

4.  The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling.

Authors:  Dan Bi; Kazuyoshi Toyama; Vincent Lemaître; Jun Takai; Fan Fan; David P Jenkins; Heike Wulff; David D Gutterman; Frank Park; Hiroto Miura
Journal:  J Biol Chem       Date:  2013-04-22       Impact factor: 5.157

Review 5.  A mitochondrial basis for Huntington's disease: therapeutic prospects.

Authors:  J Chakraborty; U Rajamma; K P Mohanakumar
Journal:  Mol Cell Biochem       Date:  2013-12-29       Impact factor: 3.396

Review 6.  Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.

Authors:  Jaume Folch; Oriol Busquets; Miren Ettcheto; Elena Sánchez-López; Ruben Dario Castro-Torres; Ester Verdaguer; Maria Luisa Garcia; Jordi Olloquequi; Gemma Casadesús; Carlos Beas-Zarate; Carme Pelegri; Jordi Vilaplana; Carme Auladell; Antoni Camins
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal Muscle.

Authors:  Jill K Morris; Colin S McCoin; Kelly N Fuller; Casey S John; Heather M Wilkins; Zachary D Green; Xiaowan Wang; Palash Sharma; Jeffrey M Burns; Eric D Vidoni; Jonathan D Mahnken; Kartik Shankar; Russell H Swerdlow; John P Thyfault
Journal:  Function (Oxf)       Date:  2021-09-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.